Patent ID: 7256194

Claim:
Compounds of the Formula (I) wherein X is H, Cl, Br, —C(═NR1)NH 2 , —CH 2 NH 2 , —NH—C(═NR1)NH 2 , —S—C(═NR1)NH 2 , —NH—C(═NH)—C(═NH)NH 2 , —C(═NH)SR1, —NH 2 , —C(═N—NH 2 )NH 2 , wherein R1 is —H, —OH, —C(═O)OR2, alkyl, aralkyl, aralkyloxy, aryloxy or a heteroalkyl group, wherein R2 is alkyl, heteroalkyl, a carbocycle, heterocycloalkyl, aryl, heteroaryl or aralkyl; Y is O, S, SO, SO 2 , SO 2 NH, PO 2 NH, NR10, CO or CR8R9 wherein R8, R9 and R10 are independently H, alkyl, heteroalkyl, carbocycle, heterocycloalkyl, aryl, heteroaryl, aralkyl or heteroarylalkyl with the exception, that if Y is NR10, X is not —(═NR1)NH 2 ; Ar is aryl, heteroaryl, heteroarylalkyl or aralkyl wherein X is directly attached to the aromatic ring system; R3 is H, an alkyl group, a heteroalkyl group, a carbocycle, a heterocycloalkyl group, an aryl group, a heteroaryl, group, a heteroarylalkyl group or an aralkyl group; R4 is H, alkyl, heteroalkyl, a carbocycle, heterocycloalkyl, aryl, heteroaryl, heteroarylalkyl or aralkyl; R5 is H, an alkyl group, a heteroalkyl group, a carbocycle, a heterocycloalkyl group, an aryl group, a heteroaryl group or an aralkyl group and R6 and R7 are independently H, alkyl, heteroalkyl, carbocycle, heterocycloalkyl, aryl, heteroaryl, aralkyl or heteroarylalkyl or are together members of a heterocycloalkyl ring system, or a heteroaryl ring system; or a pharmacologically acceptable salt, solvate, hydrate, prodrug or formulation thereof.